Search Orphan Drug Designations and Approvals
-
| Generic Name: | Recombinant immunotoxin combining the functional components of antibody against mesothelin and the enzymatic activity of a pseudomonas exotoxin |
|---|---|
| Date Designated: | 02/11/2002 |
| Orphan Designation: | Treatment of epithelial ovarian cancer |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
National Institutes of Health Cancer Therapy Evaluation Program/DCTD/NCI Suite 7111 Rockville, Maryland 20852 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







